Drug development in oncology occurs mainly at the interface of pharma/biotech companies and academic research centres.

Each party needs to bring specific expertise, facilities and skills to the arena in order to be successful in bringing new therapies to the market.

This 3-day educational program teaches knowledge and skills needed by professionals in both the corporate and the academic environment.

It is the continuation of a highly successful programme offered annually since 2004.

Educational program

The educational program will provide thorough introductions by renowned experts into various aspects of cancer and will cover the complete development process and several closely associated areas:

• essentials of tumour biology 
• oncopathology
• essentials of medical oncology  
• essentials of haemato-oncology
• essentials of tumour immunology and immunotherapy of cancer  
• preclinical drug development
• early-phase clinical studies
• late-phase clinical development
• post-registration clinical studies
• molecular diagnostics and biomarkers for targeted cancer therapy
• biostatical and regulatory issues